Janssen Korea, Hong Kong & Taiwan – Kim Oak-Yeon, Managing Director
Janssen’s managing director in Korea discusses the groups long and significant commitment to R&D in the country, as well as some of the challenges that one of the most innovative…
Janssen Korea, as Korea operation of the pharmaceutical company of Johnson & Johnson, started as a joint company with the Yuhan Corporation in 1983. For the last 30 years, we have been committed to delivering innovative treatments for serious unmet medical needs, across the following five therapeutic areas: Cardiovascular and Metabolism, Neuroscience, Immunology, Oncology and hematology, and Infectious Diseases and Vaccines. Janssen Korea prepared a production based facility building, a factory in Hwaseong, Gyeonggi-do, in 1983. Hyangnam factory has grown into the base factory of Janssen in the Asia-Pacific region through production innovation and was promoted to be the production base factory of the pharmaceutical division of Johnson & Johnson, included in GPSG (Global Pharmaceutical Supply Group), in January 2009. The factory is exporting complete products to 8 Asian countries, Taiwan, HongKong, Vietnam, The Philippines, Thailand, Malaysia, Singapore and Indonesia.
Contact Details:
Janssen Korea Ltd.
Address: 25-26Fl., LS Youngsan Tower, 92, Hangang-daero, Yongsan-gu, Seoul, Korea 140-702
Tel.: +82-2-2094-4500
Homepage: http://www.janssenkorea.com/
Janssen’s managing director in Korea discusses the groups long and significant commitment to R&D in the country, as well as some of the challenges that one of the most innovative…
J&J India’s Jayashri Kulkarni lays out her approach to comprehensive leadership, drawing on her diverse career history across various sectors; her mandate to leverage innovative assets to transform disease management…
Portugal boasts a well-developed universal healthcare system and saw healthcare spending increase by 6.2 percent annually between 2016 and 2021, according to the OECD. However, the representatives of innovative medicines…
Speaking to PharmaBoardroom as Janseen is rebranding as Johnson & Johnson Innovative Medicine, managing director for Portugal, Filipa Mota e Costa, discusses the affiliate’s expanded local footprint and its ranking…
Encircled by heavyweight life sciences powerhouses of the likes of Germany, France and Switzerland, plucky Belgium nonetheless continues to astonish and project considerable influence when it comes to its abilities…
As profit margins in established markets decreased, “pharmerging markets” became the new El Dorado for pharma and medtech companies in the 2010s. Many put in big investments only to discover…
Janssen has the lofty aim of reaching USD 60bn dollars in sales by 2025, an 8bn increase on the 2021 figure, despite some high-profile losses of exclusivity and the spin-off…
Maria Fernanda Prado highlights some of the lessons drawn from her extensive experience in emerging markets which remain applicable in her current role as Janssen’s managing director for the Benelux…
After 15 years of economic struggles coupled with political swings to the left and right, Greece seems to be on its surest footing in decades. Indeed, the Economist observed that…
A roundup of some of the biggest pharma and biotech news from China including the collaboration between Elektr and Sinopharm; Biocytogen’s partnership with Janssen and deal with Chipscreen Biosciences; China’s…
Christian Rodseth, VP and managing director for Janssen’s Greece, Poland, and Romania cluster, outlines the multifaceted strengths of his teams, the part of the Janssen portfolio he is most excited…
China’s strict ‘dynamic COVID-zero’ policy, relying on lockdowns, mass-testing and border controls to stamp out COVID-19 outbreaks wherever they appear, has undoubtedly constricted the country’s economic growth and prompted uncommon…
Through compassionate use programs patients suffering from critical, life-threatening conditions can access potential life-saving therapeutic options which have not been formally approved by the responsible health authority in an ethical…
See our Cookie Privacy Policy Here
